Xoma reported $-4767000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US $ -44972000 8.98M
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
Ardelyx ARDX:US $ -26215000 1.59M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Bluebird Bio BLUE:US $ -100761000 19.58M
Celldex Therapeutics CLDX:US $ -21396000 1.86M
Chimerix CMRX:US -23447000 1.32M
Curis CRIS:US $ -15061000 72K
Eli Lilly And LLY:US $ 1650.5M 919.4M
Emergent Biosolutions EBS:US $ -72000000 78.4M
Epizyme EPZM:US $ -29806000 21.12M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Life Technologies LIFE:US $ -12584000 206K
Macrogenics MGNX:US $ -41808000 24.83M
Novartis NOVN:VX 3.32B 176M
Novartis NVS:US 3.32B 176M
Pfizer PFE:US $ 12099M 2104M
Prothena PRTA:US -43209000 5.26M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Teva Pharmaceutical Industries TEVA:US 734M 55M
Xoma XOMA:US $ -4767000 2.7M
YTE INCY:US $ 260.29M 132.62M